CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
DEL PRIS
SecurityDE:MX4A / CME Group Inc.
InstitutionState Street Corp
Latest Disclosed Ownership16,497,809 shares
Ownership 4.60%
State Street Corp ownership in MX4A / CME Group Inc.

2019-02-12 - State Street Corp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16,497,809 shares of CME Group Inc. (DE:MX4A). This represents 4.6 percent ownership of the company. In their previous filing dated 2018-02-14 , State Street Corp had reported owning 17,519,760 shares, indicating a decrease of -5.83 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2019-02-12 2019-02-12 13G/A 17,519,760 16,497,809 -5.83 4.60 -10.68
2018-02-14 2018-02-14 13G 17,989,691 17,519,760 -2.61 5.15 -2.83
2017-02-09 2017-02-09 13G 17,989,691 5.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CME GROUP COM 12572Q105 16,055,287 -89,238 -0.55 4,741,929 7.56 0.1637
2026-02-13 2025-12-31 13F CME GROUP COM 12572Q105 16,144,525 56,725 0.35 4,408,747 1.43 0.1479
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 16,087,800 -331,396 -2.02 4,346,763 -3.95 0.1507
2025-08-14 2025-06-30 13F CME GROUP COM 12572Q105 16,419,196 -19,968 -0.12 4,525,459 3.77 0.1696
2025-05-15 2025-03-31 13F CME GROUP COM 12572Q105 16,439,164 337,761 2.10 4,361,146 13.82 0.1797
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 16,101,403 203,443 1.28 3,831,652 9.23 0.1512
2024-11-14 2024-09-30 13F CME GROUP COM 12572Q105 15,897,960 -119,442 -0.75 3,507,885 11.40 0.1427
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 16,017,402 306,285 1.95 3,149,021 -6.90 0.1376
2024-05-15 2024-03-31 13F CME GROUP COM 12572Q105 15,711,117 -194,755 -1.22 3,382,446 -1.45 0.1512
2024-02-14 2023-12-31 13F CME GROUP COM 12572Q105 15,905,872 361,727 2.33 3,432,114 10.28 0.1669
2023-11-14 2023-09-30 13F CME GROUP COM 12572Q105 15,544,145 -406,314 -2.55 3,112,249 5.31 0.1726
2023-08-14 2023-06-30 13F CME GROUP COM 12572Q105 15,950,459 555,878 3.61 2,955,461 0.24 0.1552
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 15,394,581 -434,712 -2.75 2,948,365 7.89 0.1664
2023-05-15 2022-12-31 13F/A-99 CME GROUP COM 12572Q105 15,829,293 194,876 1.25 2,732,682 -1.32 0.1606
2023-05-15 2022-12-31 13F CME GROUP COM 12572Q105 15,829,293 194,876 2,732,682 0.1606
2022-11-15 2022-09-30 13F CME GROUP COM 12572Q105 15,634,417 -34,251 -0.22 2,769,324 -13.66 0.1752
2022-08-15 2022-06-30 13F CME GROUP COM 12572Q105 15,668,668 -1,115,802 -6.65 3,207,376 -19.66 0.1922
2022-05-16 2022-03-31 13F CME GROUP COM 12572Q105 16,784,470 -78,076 -0.46 3,992,354 2.20 0.1974
2022-02-14 2021-12-31 13F CME GROUP COM 12572Q105 16,862,546 377,321 2.29 3,906,238 22.53 0.1852
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 16,485,225 -325,692 -1.94 3,187,913 -10.84 0.1685
2021-08-16 2021-06-30 13F CME GROUP COM 12572Q105 16,810,917 -73,357 -0.43 3,575,346 3.69 0.1884
2021-07-09 2021-03-31 13F/A-1 CME GROUP COM 12572Q105 16,884,274 392,407 2.38 3,448,275 13.31 0.1977
2021-05-17 2021-03-31 13F CME GROUP COM 12572Q105 16,884,274 392,407 3,448,275 0.1977
2021-02-16 2020-12-31 13F CME GROUP COM 12572Q105 16,491,867 528,192 3.31 3,043,154 13.94 0.1863
2020-11-10 2020-09-30 13F CME GROUP COM 12572Q105 15,963,675 -90,465 -0.56 2,670,882 2.35 0.1823
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 16,054,140 31,962 0.20 2,609,440 -5.81 0.1897
2020-06-19 2020-03-31 13F/A-1 CME GROUP COM 12572Q105 16,022,178 -427,732 -2.60 2,770,395 -17.12 0.2423
2020-05-11 2020-03-31 13F CME GROUP COM 12572Q105 16,022,178 -427,732 2,770,395 243,296.4636
2020-02-06 2019-12-31 13F CME GROUP COM 12572Q105 16,449,910 90,579 0.55 3,342,845 -3.31 0.2290
2019-11-14 2019-09-30 13F CME GROUP COM 12572Q105 16,359,331 -192,319 -1.16 3,457,381 7.61 0.2577
2019-08-14 2019-06-30 13F CME GROUP COM 12572Q105 16,551,650 183,048 1.12 3,212,841 19.26 0.2396
2019-05-15 2019-03-31 13F CME GROUP COM CL A 12572Q105 16,368,602 276,861 1.72 2,693,945 -11.82 0.2102
2019-02-12 2018-12-31 13F CME GROUP COM CL A 12572Q105 16,091,741 -9,680 -0.06 3,055,189 11.48 0.2782
2018-11-09 2018-09-30 13F CME GROUP Common equity shares 12572Q105 16,101,421 434,043 2.77 2,740,616 6.71 0.2105
2018-08-14 2018-06-30 13F CME GROUP Common equity shares 12572Q105 15,667,378 976,811 6.65 2,568,197 8.09 0.2147
2018-05-15 2018-03-31 13F CME GROUP Common equity shares 12572Q105 14,690,567 -2,027,241 -12.13 2,376,049 -2.89 0.2017
2018-02-14 2017-12-31 13F CME GROUP Common equity shares 12572Q105 16,717,808 -416,881 -2.43 2,446,800 5.25 0.1968
2017-11-14 2017-09-30 13F CME GROUP Common equity shares 12572Q105 17,134,689 -262,995 -1.51 2,324,840 6.70 0.2006
2017-08-14 2017-06-30 13F CME GROUP Common equity shares 12572Q105 17,397,684 -301,988 -1.71 2,178,884 3.62 0.1927
2017-05-15 2017-03-31 13F CME GROUP Common equity shares 12572Q105 17,699,672 -286,653 -1.59 2,102,710 0.85 0.1876
2017-02-09 2016-12-31 13F CME GROUP Common equity shares 12572Q105 17,986,325 977,421 5.75 2,084,930 17.28 0.1962
2017-01-13 2016-09-30 13F/A-1 CME GROUP Common equity shares 12572Q105 17,008,904 3,795,562 28.73 1,777,773 38.14 0.1792
2016-11-14 2016-09-30 13F CME GROUP Common equity shares 12572Q105 13,327,974 1,393,042
2016-08-12 2016-06-30 13F CME GROUP Common equity shares 12572Q105 13,213,342 -132,024 -0.99 1,286,973 0.40 0.1383
2016-05-20 2016-03-31 13F/A-1 CME GROUP Common equity shares 12572Q105 13,345,366 8,002 0.06 1,281,811 6.08 0.1386
2016-05-12 2016-03-31 13F CME GROUP Common equity shares 12572Q105 13,345,366 1,281,811
2016-02-16 2015-12-31 13F CME GROUP Common equity shares 12572Q105 13,337,364 260,649 1.99 1,208,376 -0.36 0.1321
2015-11-16 2015-09-30 13F CME GROUP Common equity shares 12572Q105 13,076,715 255,655 1.99 1,212,732 1.64 0.1412
2015-08-13 2015-06-30 13F CME GROUP Common equity shares 12572Q105 12,821,060 -577,269 -4.31 1,193,138 -5.97 0.1275
2015-05-15 2015-03-31 13F CME GROUP Common equity shares 12572Q105 13,398,329 -560,913 -4.02 1,268,952 2.54 0.1302
2015-02-11 2014-12-31 13F CME GROUP Common equity shares 12572Q105 13,959,242 394,432 2.91 1,237,485 14.10 0.1233
2014-11-12 2014-09-30 13F/A-1 CME GROUP Common equity shares 12572Q105 13,564,810 429,030 3.27 1,084,584 16.37 0.1167
2014-11-10 2014-09-30 13F CME GROUP Common equity shares 12572Q105 13,564,810 1,084,584
2014-08-12 2014-06-30 13F CME GROUP Common equity shares 12572Q105 13,135,780 -60,368 -0.46 931,982 -4.57 0.1006
2014-05-15 2014-03-31 13F/A-1 CME GROUP Common equity shares 12572Q105 13,196,148 -483,243 -3.53 976,645 -9.00 0.1110
2014-05-13 2014-03-31 13F CME GROUP Common equity shares 12572Q105 13,196,148 976,645
2014-02-06 2013-12-31 13F/A-1 CME GROUP Common equity shares 12572Q105 13,679,391 429,749 3.24 1,073,278 9.64 0.1194
2014-02-06 2013-12-31 13F CME GROUP Common equity shares 12572Q105 12,884,177 653,346
2013-11-12 2013-09-30 13F CME GROUP Common equity shares 12572Q105 13,249,642 78,862 0.60 978,894 -2.18 0.1206
2013-08-08 2013-06-30 13F CME GROUP Common equity shares 12572Q105 13,170,780 13,170,780 1,000,719 0.1305
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.